Pristimerin, a quinonemethide triterpenoid, induces apoptosis in pancreatic cancer cells through the inhibition of pro-survival Akt/NF-κB/mTOR signaling proteins and anti-apoptotic Bcl-2

Author:          

Publisher: Spandidos Publications

ISSN: 1019-6439

Source: International Journal of Oncology, Vol.44, Iss.5, 2014-01, pp. : 1707-1715

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content